New Treatment for Vitiligo

Vitiligo develops when the cells in our body responsible for producing pigment, also called melanocytes are killed by the body's immune system. This results in depigmentation or white lesions or blotches in affected areas. While there are multiple treatment options for vitiligo and other types of leukodermas, MKTP offers long-term benefits of re-pigmentation. Non-cultured Melanocyte-Keratinocyte Transplantation Procedure (MKTP) is the latest modification to surgical management to vitiligo and other leukodermas.